drugset / Trial / NCT00719108

Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.

NCT00719108

Phase 1 Completed 42 enrolled Wockhardt
RandomizedCrossoverQuadruple-blindHealth-services research

Summary

The aim of this trial is to demonstrate bioequivalence of Wosulin R to Actrapid with regard to its total and to its maximum serum insulin concentrations.

Timeline

Start
2008-07
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 0.3 iu/kg Intravenous
Subject Wosulin R Protein / enzyme biologic 0.3 iu/kg Intravenous

Indications